Anavex Life Sciences Corp (AVXL)

Anavex Life Sciences Corp (AVXL) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
	203.90%-6.74	6.48	6.78	10.84	14.46
Selling, General, and Administrative	11.34%2.03	2.29	2.13	-	-
Operating Income/Loss	203.90%6.74	-6.48	-6.78	-10.84	-14.46
Net Interest Income/Expense	1.04%1.07	1.06	1.08	1.00	1.08
Nonoperating Income/Loss	5.15%1.09	1.15	1.12	1.02	1.22
Income Tax Expense/Benefit	-	-	0.02	-	-
	246.57%7.82	-5.34	-5.68	-9.83	-13.24
Attributable To Parent	246.57%7.82	-5.34	-5.68	-9.83	-13.24
Available To Common Stockholders, Basic	7.82	-	-5.68	-9.83	-13.24
Basic Average Shares	99,923%92,696.84	92.68	89.03	0.20	85.38
Diluted Average Shares	100.14K%92,899.54	92.68	89.03	0.20	85.38
Basic Earnings Per Share	233.33%0.08	-0.06	-0.06	-0.11	-0.16
Diluted Earnings Per Share	233.33%0.08	-0.06	-0.06	-0.11	-0.16